<DOC>
	<DOC>NCT02592161</DOC>
	<brief_summary>A randomized, single center, double blind, parallel, placebo-controlled, clinical study of efficacy and safety of Chung A Won and placebo for 24 weeks three times a day on the improvement of osteoporosis and symptoms in Women's older than 50 patients with osteoporosis.</brief_summary>
	<brief_title>Clinical Study of Efficacy and Safety of Chung A Won in Women's Patients With Osteoporosis</brief_title>
	<detailed_description />
	<mesh_term>Osteoporosis</mesh_term>
	<criteria>1)Female more than 50 years old in osteoporosis 1. Wash out peroid: using agents more than 3 months against osteoporosis 2. Subject who takes drugs that may affect the clinical trials (Corticosteroids, anticonvulsants, tranquilizers, antidepressants, hypnotic, diuretic) 3. Subject who has a chronic liver disease, thyroid disease and chronic renal disease 4. Subject who is chronic alcoholics and undernourished 5. Other conditions were not suitable in study : Severe physical defects mental defects 6. Pregnant woman 7. Subject who is not calibrated hypercalcemia/hypocalcemia 8. Secondary osteoporosis : Subject who takes drugs(Glucocorticoid, Diabetes Medications) 9. Subject who has 60% more fracture risk in FRAX(WHO fracture risk assessment tool)</criteria>
	<gender>Female</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>